Answer: Monoamine oxidase inhibitors will elevate the concentration of norepinephrine in the synapse.
Explanation: Monoamine oxidase is an enzyme that catalyzes the removal of monoamines such as norepinephrine, serotonin and dopamine from the brain. Monoamines are neurotransmitters involved in the transmission of nerve impulses in the brain. Monoamine oxidase inhibitors prevent the removal of these neurotransmitters thereby making them more available in the synapse. MAOIs inhibit the action of monoamine oxidase which catalyzes the removal of norepinephrine from the synapse thereby raising the level of norepinephrine in the synapse.
